{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:28:29Z","timestamp":1777951709534,"version":"3.51.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Therapeutic options for critical infections by carbapenem-resistant Enterobacterales (CRE) are largely limited to polymyxins in India. They have significant toxicity, unpredictable kinetics and prohibitive cost. The objective of the current study was to find the mechanisms of resistance in CRE and to evaluate the in vitro efficacy of potential treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prospective study performed during October 2023\u2013March 2024, all Enterobacterales clinical isolates of our laboratory were screened for carbapenem resistance. All CRE isolates were phenotypically and genotypically tested for mechanisms of resistance and underwent extended antimicrobial susceptibility testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 12.90% (100\/775) of Enterobacterales were CRE, among which 99% (99\/100) were multidrug resistant. Phenotypic metallo-beta-lactamase screening was positive in 87\/100 (87%) of isolates. Aztreonam-avibactam was found to effectively inhibit 96% of isolates, while cefiderocol effectively inhibited 87%. Two isolates resistant to aztreonam-avibactam were susceptible to cefiderocol, both of which harboured blaNDM. The blaNDM gene was detected in 87% of the isolates, one of which also co-harboured blaKPC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study showed an exceptionally high prevalence of the blaNDM gene among CRE clinical isolates. Either aztreonam-avibactam or cefiderocol was found to be effective against 98% of CRE isolates highlighting the immediate need of making these two drugs accessible to patients in India.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag022","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:42:41Z","timestamp":1773924161000},"page":"575-581","source":"Crossref","is-referenced-by-count":0,"title":["Outstanding presence of New Delhi metallo-beta-lactamase in carbapenem-resistant\n                    <i>Enterobacterales<\/i>\n                    and exceptionally potent in vitro activity of cefiderocol and aztreonam-avibactam emphasises their immediate access in India"],"prefix":"10.1093","volume":"120","author":[{"given":"Mallika","family":"Sengupta","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Kalyani, West Bengal 741245 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshetrimayum","family":"Ammy","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Kalyani, West Bengal 741245 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indranil","family":"Banik","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Kalyani, West Bengal 741245 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujjala","family":"Ghoshal","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Kalyani, West Bengal 741245 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-4958","authenticated-orcid":false,"given":"Sayantan","family":"Banerjee","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Kalyani, West Bengal 741245 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2026050406270024800_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2013.00048","article-title":"Stormy waters ahead\u201d: global emergence of carbapenemases","volume":"4","author":"Patel","year":"2013","journal-title":"Front Microbiol"},{"key":"2026050406270024800_bib2","doi-asserted-by":"crossref","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","article-title":"Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy","volume":"266","author":"Ma","year":"2023","journal-title":"Microbiol Res"},{"key":"2026050406270024800_bib3"},{"issue":"10459","key":"2026050406270024800_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"2026050406270024800_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018\u20132022","volume":"37","author":"Wise","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"2026050406270024800_bib6","author":"ICMR"},{"issue":"3","key":"2026050406270024800_bib7","first-page":"150","article-title":"Prevalence and molecular characterization of carbapenem resistant gram-negative bacilli in a tertiary care hospital in Mumbai","volume":"9","author":"Prabhala","year":"2023","journal-title":"IP Int J Med Microbiol Trop Dis"},{"issue":"1","key":"2026050406270024800_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-022-00549-9","article-title":"Trends in carbapenem resistance in pre-COVID and COVID times in a tertiary care hospital in North India","volume":"22","author":"Chatterjee","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"2026050406270024800_bib9","first-page":"43","article-title":"Current trends of carbapenemase production amongst multi-drug resistant gram-negative bacteria in a tertiary-care hospital in West Bengal","volume":"27","author":"Chakravarty","year":"2025","journal-title":"JK Science"},{"issue":"3","key":"2026050406270024800_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/ijmm.IJMM_18_326","article-title":"Newer \u03b2-lactam\/\u03b2-lactamase inhibitor for multidrug-resistant gram-negative infections: challenges, implications and surveillance strategy for India","volume":"36","author":"Veeraraghavan","year":"2018","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"2026050406270024800_bib11","doi-asserted-by":"crossref","first-page":"e01454","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026050406270024800_bib12","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2147\/IDR.S378579","article-title":"Analysis of in vitro activity of cefiderocol against carbapenem-resistant gram-negative Bacilli by Broth microdilution and disk diffusion method: a single-center study in Odisha, India","volume":"15","author":"Nayak","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"10","key":"2026050406270024800_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/mdr.2023.0090","article-title":"In vitro activity of cefiderocol against carbapenem-resistant enterobacterales and Pseudomonas aeruginosa","volume":"29","author":"Malisova","year":"2023","journal-title":"Microb Drug Resist Larchmt N"},{"key":"2026050406270024800_bib14","author":"ICMR"},{"key":"2026050406270024800_bib15","author":"CLSI","year":"2023"},{"issue":"9","key":"2026050406270024800_bib16","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.02837-13","article-title":"Faropenem disks for screening of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae","volume":"52","author":"Hu","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2026050406270024800_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1995-7645(12)60113-8","article-title":"Metallo\u2013 \u03b2\u2014lactamase producing nonfermentative gram\u2013negative bacteria: an increasing clinical threat among hospitalized patients","volume":"5","author":"Gupta","year":"2012","journal-title":"Asian Pac J Trop Med"},{"issue":"1","key":"2026050406270024800_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijmmb.2021.12.006","article-title":"Susceptibility testing for aztreonam plus ceftazidime\/avibactam combination: a general guidance for clinical microbiology laboratories in India","volume":"40","author":"Bakthavatchalam","year":"2022","journal-title":"Indian J Med Microbiol"},{"issue":"11","key":"2026050406270024800_bib19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/aac.00846-21","article-title":"Evaluation of susceptibility testing methods for Aztreonam and Ceftazidime-avibactam combination therapy on extensively drug-resistant gram-negative organisms","volume":"65","author":"Khan","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2026050406270024800_bib20","doi-asserted-by":"crossref","first-page":"115652","DOI":"10.1016\/j.diagmicrobio.2022.115652","article-title":"In vitro activity of Ceftazidime-Avibactam and its comparators against carbapenem resistant enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019","volume":"103","author":"Bakthavatchalam","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"2026050406270024800_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijmm.IJMM_16_386","article-title":"Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: a molecular study from India","volume":"35","author":"Mohanty","year":"2017","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"2026050406270024800_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijmm.IJMM_19_189","article-title":"Will ceftazidime\/avibactam plus aztreonam be effective for NDM and OXA-48-like producing organisms: lessons learnt from In vitro study","volume":"37","author":"Pragasam","year":"2019","journal-title":"Indian J Med Microbiol"},{"issue":"9","key":"2026050406270024800_bib23","doi-asserted-by":"crossref","first-page":"e00472","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2026050406270024800_bib24","doi-asserted-by":"crossref","first-page":"e00847","DOI":"10.1128\/spectrum.00847-23","article-title":"In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam\/aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India","volume":"11","author":"Borde","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"12","key":"2026050406270024800_bib25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jiac.2024.05.017","article-title":"In vitro assessment of newer colistin-sparing antimicrobial agents for clinical isolates of carbapenem-resistant organisms","volume":"30","author":"Saxena","year":"2024","journal-title":"J Infect Chemother"},{"key":"2026050406270024800_bib26","doi-asserted-by":"crossref","first-page":"100556","DOI":"10.1016\/j.ijmmb.2024.100556","article-title":"In vitro activity of the newly approved antimicrobial agent Cefiderocol against carbapenem resistant gram negative clinical isolates","volume":"48","author":"Khanchandani","year":"2024","journal-title":"Indian J Med Microbiol"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/5\/575\/67481323\/trag022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/5\/575\/67481323\/trag022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:27:09Z","timestamp":1777890429000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/120\/5\/575\/8537399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag022","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,23]]}}}